Elliptic Laboratories A EBIT per Share
The EBIT per Share of Elliptic Laboratories A (ELABS.OL) as of Oct 13, 2026 is -0.35 NOK. In the previous year, EBIT per Share was 0.04 NOK — a change of -920.80% (lower).
Get this data via API
Financial Data API
EBIT per Share
-0.35NOK
YoY
-920.80%
Last updated:
EBIT per Share of Elliptic Laboratories A is 2025 -0.35 NOK. EBIT per Share of Elliptic Laboratories A was 2024 0.04 NOK. It decreases by -920.80% lower compared to the previous year.
The Elliptic Laboratories A EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2021
-0.12 NOK
Jan 1, 2022
-0.41 NOK
Jan 1, 2023
-0.47 NOK
Jan 1, 2024
0.04 NOK
Jan 1, 2025
-0.35 NOK
Jan 1, 2026 (e)
-0.14 NOK
Jan 1, 2027 (e)
-0.00 NOK
Jan 1, 2028 (e)
0.09 NOK
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | 0.09NOK | -100,039.98% |
| est | -0.00NOK | -99.93% |
| est | -0.14NOK | -59.56% |
| -0.35NOK | -920.80% | |
| 0.04NOK | -109.06% | |
| -0.47NOK | +17.09% | |
| -0.41NOK | +245.15% | |
| -0.12NOK | -18.42% | |
| -0.14NOK | +1.91% | |
| -0.14NOK | -41.10% | |
| -0.24NOK | -27.18% | |
| -0.33NOK | — |
Access this data via the Eulerpool API
Elliptic Laboratories A Stock analysis
What does Elliptic Laboratories A do? Elliptic Laboratories A is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Elliptic Laboratories A stock
EBIT per Share of Elliptic Laboratories A is -0.35 NOK in 2025.
EBIT per Share of Elliptic Laboratories A changed from 0.04 NOK to -0.35 NOK, representing a -920.80% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Elliptic Laboratories A since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Elliptic Laboratories A
All Key Metrics — Elliptic Laboratories A
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth